Literature DB >> 12678829

Non-peptidic inhibitors of cysteine proteases.

T Schirmeister1, U Kaeppler.   

Abstract

In comparison to the huge number of peptidic and peptidomimetic inhibitors of cysteine proteases which have been developed during the last twenty years the number of non-peptidic compounds with cysteine protease inhibiting properties is restricted to a few substance classes. In contrast to peptidic and peptidomimetic inhibitors the non-peptidic lead structures have mainly been discovered by computational or enzymatic industrial screenings and not by a rational approach. But, the growing number of resolved X-ray structures of the target enzymes as well as molecular modeling methods have supported the further development of potent inhibitors beginning from these lead structures. In this review we will focus on new non-peptidic cysteine protease inhibitors which have been developed during the last years. Discovery, structure-activity-relationship and inhibition mechanisms will be discussed.

Mesh:

Substances:

Year:  2003        PMID: 12678829     DOI: 10.2174/1389557033488079

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  10 in total

1.  Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability.

Authors:  Jeffery D Zwicker; Nicolas A Diaz; Alfredo J Guerra; Paul D Kirchhoff; Bo Wen; Duxin Sun; Vern B Carruthers; Scott D Larsen
Journal:  Bioorg Med Chem Lett       Date:  2018-03-09       Impact factor: 2.823

2.  Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.

Authors:  Michael C Myers; Parag P Shah; Mary Pat Beavers; Andrew D Napper; Scott L Diamond; Amos B Smith; Donna M Huryn
Journal:  Bioorg Med Chem Lett       Date:  2008-05-01       Impact factor: 2.823

3.  Inhibitory effects of ethacrynic acid analogues lacking the α,β-unsaturated carbonyl unit and para-acylated phenols on human cancer cells.

Authors:  Zack E Bryant; Romy F J Janser; Medina Jabarkhail; Melissa S Candelaria-Lyons; Brittni B Romero; Severine Van slambrouck; Wim F A Steelant; Ingo Janser
Journal:  Bioorg Med Chem Lett       Date:  2010-12-19       Impact factor: 2.823

4.  Design, synthesis and biological evaluation of a library of thiocarbazates and their activity as cysteine protease inhibitors.

Authors:  Zhuqing Liu; Michael C Myers; Parag P Shah; Mary Pat Beavers; Phillip A Benedetti; Scott L Diamond; Amos B Smith; Donna M Huryn
Journal:  Comb Chem High Throughput Screen       Date:  2010-05       Impact factor: 1.339

5.  Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor.

Authors:  Michael C Myers; Parag P Shah; Scott L Diamond; Donna M Huryn; Amos B Smith
Journal:  Bioorg Med Chem Lett       Date:  2007-11-01       Impact factor: 2.823

6.  Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assays.

Authors:  Michael C Myers; Andrew D Napper; Nuzhat Motlekar; Parag P Shah; Chun-Hao Chiu; Mary Pat Beavers; Scott L Diamond; Donna M Huryn; Amos B Smith
Journal:  Bioorg Med Chem Lett       Date:  2007-07-05       Impact factor: 2.823

Review 7.  The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L.

Authors:  Donna M Huryn; Amos B Smith
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

8.  Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay.

Authors:  Helton J Wiggers; Josmar R Rocha; William B Fernandes; Renata Sesti-Costa; Zumira A Carneiro; Juliana Cheleski; Albérico B F da Silva; Luiz Juliano; Maria H S Cezari; João S Silva; James H McKerrow; Carlos A Montanari
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

9.  Design, synthesis, conformational and molecular docking study of some novel acyl hydrazone based molecular hybrids as antimalarial and antimicrobial agents.

Authors:  Parvin Kumar; Kulbir Kadyan; Meenakshi Duhan; Jayant Sindhu; Vineeta Singh; Baljeet Singh Saharan
Journal:  Chem Cent J       Date:  2017-11-14       Impact factor: 4.215

10.  Identification of novel small molecules as inhibitors of hepatitis C virus by structure-based virtual screening.

Authors:  Jing Li; Xian Liu; Shanshan Li; Yulan Wang; Nannan Zhou; Cheng Luo; Xiaomin Luo; Mingyue Zheng; Hualiang Jiang; Kaixian Chen
Journal:  Int J Mol Sci       Date:  2013-11-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.